JP Morgan Chase’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding GLSI
VCM
N
VPM
VFT
JP Morgan Chase's GLSI Position: Q1 2026 in Review
JP Morgan Chase reduced its Greenwich LifeSciences (GLSI) stake by 2.7% in Q1 2026, selling an estimated $1.9K and leaving 2,604 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #6149.
JP Morgan Chase first reported a position in GLSI in Q2 2021 and has held it in 20 quarters since. The position peaked at $216K in Q2 2021. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.
- JP Morgan Chase held 2,604 shares of Greenwich LifeSciences worth $56K as of Q1 2026.
- JP Morgan Chase sold 73 Greenwich LifeSciences shares in Q1 2026, an estimated $1.9K.
- Greenwich LifeSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6149 holding.
- JP Morgan Chase first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 20 quarters since.
- JP Morgan Chase's Greenwich LifeSciences position peaked at $216K in Q2 2021.
- 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.